Your browser doesn't support javascript.
loading
A novel mutation in SLC39A14 causing hypermanganesemia associated with infantile onset dystonia.
Juneja, Monica; Shamim, Uzma; Joshi, Aditi; Mathur, Aaradhna; Uppili, Bharathram; Sairam, Smitha; Ambawat, Sakshi; Dixit, Rashmi; Faruq, Mohammed.
Afiliação
  • Juneja M; Department of Pediatrics, Maulana Azad Medical College, New Delhi, India.
  • Shamim U; Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.
  • Joshi A; Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.
  • Mathur A; Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.
  • Uppili B; Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.
  • Sairam S; Child Development Centre, Department of Paediatrics Maulana Azad Medical College, New Delhi, India.
  • Ambawat S; Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.
  • Dixit R; Department of Radiodiagnosis, Maulana Azad Medical College, New Delhi, India.
  • Faruq M; Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.
J Gene Med ; 20(4): e3012, 2018 04.
Article em En | MEDLINE | ID: mdl-29498153
ABSTRACT

BACKGROUND:

Mutations in SLC39A14 cause a recessive disorder of manganese (Mn) metabolism that manifests as childhood onset progressive neurodegeneration characterized by parkinsonism and dystonia.

METHODS:

The present study genetically investigated a case of hypermanganesemia. We describe a family where an affected child with a history of progressive neurodegeneration showed symptoms of dystonia with increased levels of blood Mn and altered signal intensities in globus pallidus and dentate nucleus. Whole exome sequencing was conducted to genetically investigate the pathology in the child, which allowed us to identify a novel homozygous causal mutation in SLC39A14.

RESULTS:

Insilico modeling of the novel homozygous causal mutation in SLC39A14 predicted that it was deleterious, affecting Mn binding and transportation of metal by transmembrane instability of the protein structure. The clinical features of other reported mutations in SLC39A14 were also reviewed and the clinical spectrum in our case conforms to the described neurological abnormalities.

CONCLUSIONS:

We conclude that the mutation identified in SLC39A14 in our case is a novel variation linked to recessive disorders of hypermaganesemia and dystonia.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Proteínas de Transporte de Cátions / Manganês / Doenças Metabólicas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Proteínas de Transporte de Cátions / Manganês / Doenças Metabólicas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant Idioma: En Ano de publicação: 2018 Tipo de documento: Article